
Omeros Corporation (($OMER)) has held its Q3 earnings call. Read on for the main highlights of the call. Omeros delivered a strongly positive earnings call, led by fast-growing YARTEMLEA sales,
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| OMER | Omeros | 13.92 | 5.42 | 63.76% |
| Name | Price | % Change | |
|---|---|---|---|
| $13.92 | +63.76% |

Omeros Corporation (($OMER)) has held its Q3 earnings call. Read on for the main highlights of the call. Omeros delivered a strongly positive earnings call, led by fast-growing YARTEMLEA sales,

The major averages were broadly lower near noon, adding to yesterday’s losses amid renewed selling in semiconductor stocks as the markets await Nvidia’s much-anticipated earnings report after the close. The

H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on Omeros today and set a price target of $33.00. Brandon Folkes’s rating is based on several factors supporting a durable

Another AI-trade rout on Monday has pressured the tech-heavy Nasdaq Composite by 2.5% to its lowest level since post-midterm Thursday, with the index now within a percentage point of 7-month

Reports Q3 revenue $35.9M, consensus $37.3M. “YARTEMLEA sales continued to grow during the third quarter, delivering consecutive quarters of positive operating cash flow,” said Gregory A. Demopulos, M.D., Omeros (OMER)’

Pre-earnings options volume in Omeros (OMER) is 1.3x normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 14.1%, or $2.43, after results are

Omeros Corporation (OMER) is scheduled to report 3rd quarter earnings on 11/16/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect Omeros Corporation to post earnings of $0.02

Omeros Corporation (OMER) is scheduled to report 3rd quarter earnings on 11/11/2026. Regarding Q3 estimates, Wall Street analysts expect Omeros Corporation to post earnings of $0.02 per share. Revenue expectations

Omeros ( ($OMER) ) has shared an update. On October 28, 2026, Omeros’ board compensation committee granted CEO Gregory A. Demopulos a performance-based stock option for up to 500,000 shares,

H.C. Wainwright views the weakness in Omeros (OMER) shares following this morning’s negative Committee for Medicinal Products for Human Use opinion as overdone. The firm sees a buying opportunity ahead
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Apr 5, 2027TBA | $1.21B | $0.16 | $49.87M | 3.32 | 8.96 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.